Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,818 | -23,814 | -46,459 | -59,674 | -61,998 |
| Depreciation Amortization | 367 | 434 | 422 | 388 | 429 |
| Other Working Capital | 5,200 | 2,404 | -1,978 | -13,115 | 2,468 |
| Other Operating Activity | 33,355 | 3,763 | 1,751 | 1,839 | 1,870 |
| Operating Cash Flow | $-15,896 | $-17,213 | $-46,264 | $-70,562 | $-57,231 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,577 | 12,221 | -17,847 | N/A | N/A |
| PPE Investments | N/A | -22 | -458 | N/A | -727 |
| Investing Cash Flow | $2,577 | $12,199 | $-18,305 | $N/A | $-727 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,784 | 13,335 | 54,014 | 66 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -29 | N/A |
| Other Financing Activity | 0 | -128 | 0 | 87,340 | 57,958 |
| Financing Cash Flow | $27,784 | $13,207 | $54,014 | $87,377 | $57,958 |
| Beginning Cash Position | 14,910 | 6,717 | 16,815 | N/A | N/A |
| End Cash Position | 29,375 | 14,910 | 6,260 | 16,815 | N/A |
| Net Cash Flow | $14,465 | $8,193 | $-10,555 | $16,815 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,896 | -17,213 | -46,264 | -70,562 | -57,231 |
| Capital Expenditure | N/A | -22 | -458 | N/A | -727 |
| Free Cash Flow | -15,896 | -17,235 | -46,722 | -70,562 | -57,958 |